Chris Furnari is an award-winning business writer covering complex and highly-regulated industries. He joined THCnet as editor-in-chief in October 2019. Prior to covering the cannabis sector, he spent nearly a decade as the driving force behind Brewbound, a leading online beer business trade publication.
Furnari also writes about the alcohol business for Forbes. He is frequently tapped to provide commentary on the beer and cannabis industries, and his analysis of industry trends has been referenced by The New York Times, CNBC, USA Today, The Boston Globe, and Cincinnati Public Radio, among others.
Furnari is a proud graduate of Santa Clara University, where he was a two-sport Division I athlete and served as the sports editor of the university's official weekly newspaper.
Harvest Health & Recreation announced Tuesday its second quarter financial results, reporting a net loss of $18.3 million, a slight improvement over the $20 million it lost during the first quarter of 2020. The vertically integrated cannabis firm, which operates 35 dispensaries in seven states, said quarter over quarter revenue increased 26%, to $55.7 million.
Canada’s Tilray (Nasdaq: TLRY) announced its second quarter financial results on Monday afternoon, reporting a net loss of $81.7 million, a substantial decrease for its first quarter net loss of $184.1 million. However, total quarter over quarter revenue for the Nanaimo, British Columbia-based cannabis firm decreased 3.2%, to $50.4 million.
Columbia Care announced Monday its second quarter financial results, reporting a net loss of $27.3 million for the three-month period ending June 30, 2020. The multistate cannabis firm also reported a net loss of nearly $48 million through the first six months of 2020, a slight improvement compared to last year.
Canada's Canopy Growth Corporation (NYSE: CGC, TSX: WEED) announced Monday its first quarter fiscal 2021 financial results, reporting a net loss of C$128 million ($95.8 million) for the three-month period ending June 30, 2020. Net revenue for the Smith Falls, Ontario-based cannabis firm increased 22%, to C$110.4 million ($82.3 million), compared to the first fiscal quarter of 2020.
The Massachusetts Cannabis Control Commission (CCC) has fined marijuana firm Revolutionary Clinics $120,000 for selling contaminated cannabis products. According to the CCC, Revolutionary Clinics distributed vaporizer cartridges that contained higher-than-allowed levels of residual solvents in late 2018 and early 2019.
Ben Larson, the CEO of Vertosa, a leading cannabis infusion technology company, believes THC and CBD-infused beverages could eventually become society's so-called seventh glass. “Our entire culture has continually developed around beverage," he said. " While infused beverages are a small percentage of the overall industry right now, it’s only because we’re in the developmental phase.”
Fresh off signing a historic 10-year contract extension worth up to $503 million with the Kansas City Chiefs, NFL superstar Patrick Mahomes has now inked a lucrative endorsement with Biosteel Sports Nutrition. The Toronto-based CPG company announced Tuesday that it had signed a multiyear deal with the 24-year-old MVP quarterback, who will receive an undisclosed equity stake in Biosteel.
Sales of adult-use cannabis in Illinois have surpassed $300 million through the first seven months of the year, the state’s Department of Financial and Professional Regulation (IDFPR) reported Monday. July marked yet another record-breaking month for recreational cannabis sales in Illinois, as adult-use dispensaries moved more than 1.2 million products and hauled in nearly $61 million.
U.S. sales of CBD are expected to grow 14% and reach $4.7 billion in sales in 2020, according to a new report from the Brightfield Group. However, growth in the CBD sector has been stunted by industry headwinds and other coronavirus-induced challenges.
The Nevada Cannabis Compliance Board (CCB) has opened an investigation into several dispensaries for allegedly selling tainted marijuana products, the agency announced Tuesday. The CCB said marijuana strain Cherry OG F3 twice failed microbial testing earlier this year. However, three Las Vegas retail shops continued to sell through inventory despite a March directive to halt sales.